ABRA
Basic information
Region (hg38): 8:106759483-106770244
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABRA gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 49 | 51 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 49 | 2 | 0 |
Variants in ABRA
This is a list of pathogenic ClinVar variants found in the ABRA region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-106761050-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
8-106761052-A-C | not specified | Uncertain significance (Jan 26, 2022) | ||
8-106761072-G-C | not specified | Uncertain significance (Jul 26, 2022) | ||
8-106761075-C-T | not specified | Uncertain significance (Feb 24, 2025) | ||
8-106761120-T-C | not specified | Uncertain significance (Apr 13, 2022) | ||
8-106761138-C-T | not specified | Uncertain significance (May 25, 2022) | ||
8-106761158-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
8-106761159-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
8-106761162-C-T | not specified | Uncertain significance (Mar 01, 2023) | ||
8-106761176-A-C | not specified | Uncertain significance (Jan 15, 2025) | ||
8-106761184-A-C | not specified | Uncertain significance (Jul 12, 2022) | ||
8-106761224-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
8-106761246-T-C | not specified | Uncertain significance (Dec 17, 2023) | ||
8-106761260-C-G | not specified | Uncertain significance (Sep 25, 2023) | ||
8-106761282-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
8-106761359-A-G | not specified | Uncertain significance (Jan 17, 2023) | ||
8-106761386-C-A | not specified | Uncertain significance (Dec 06, 2024) | ||
8-106761389-A-G | not specified | Uncertain significance (Feb 18, 2025) | ||
8-106761408-A-G | not specified | Uncertain significance (Jan 08, 2025) | ||
8-106761491-A-G | not specified | Uncertain significance (Oct 29, 2024) | ||
8-106761500-G-A | not specified | Uncertain significance (Dec 25, 2024) | ||
8-106769530-G-T | not specified | Uncertain significance (Apr 12, 2024) | ||
8-106769538-C-T | not specified | Uncertain significance (Nov 02, 2023) | ||
8-106769539-G-A | not specified | Uncertain significance (Dec 14, 2022) | ||
8-106769571-T-C | not specified | Uncertain significance (Aug 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABRA | protein_coding | protein_coding | ENST00000311955 | 2 | 10763 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000615 | 0.710 | 125694 | 0 | 53 | 125747 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.152 | 233 | 227 | 1.03 | 0.0000135 | 2503 |
Missense in Polyphen | 82 | 73.926 | 1.1092 | 850 | ||
Synonymous | -1.41 | 100 | 83.6 | 1.20 | 0.00000526 | 738 |
Loss of Function | 1.09 | 10 | 14.5 | 0.691 | 8.11e-7 | 162 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000499 | 0.000499 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.000462 | 0.000462 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000108 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as an activator of serum response factor (SRF)- dependent transcription possibly by inducing nuclear translocation of MKL1 or MKL2 and through a mechanism requiring Rho-actin signaling. {ECO:0000250|UniProtKB:Q8BUZ1}.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.162
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 38.98
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0118
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abra
- Phenotype
- homeostasis/metabolism phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- abraa
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- increased curvature
Gene ontology
- Biological process
- obsolete protein import into nucleus, translocation;positive regulation of Rho protein signal transduction;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of DNA-binding transcription factor activity
- Cellular component
- plasma membrane;actin cytoskeleton;sarcomere
- Molecular function
- actin binding